Carlton North, Australia

Timothy Matthias Morgon

This inventor holds 1 USPTO granted patent. Top assignee: Acrux Dds Pty Ltd. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy Matthias Morgon. Retrieved from https://idiyas.com/inventor/timothy-matthias-morgon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 158(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Timothy Matthias Morgon

Introduction

Timothy Matthias Morgon is a notable inventor based in Carlton North, Australia. He has made significant contributions to the field of medical technology, particularly in the development of drug delivery systems. His work focuses on improving the administration of therapeutic agents for various medical conditions.

Latest Patents

Morgon holds a patent for a transdermal delivery system specifically designed for antiparkinson agents. This innovative system includes a therapeutically effective amount of an antiParkinson agent, at least one dermal penetration enhancer that is a safe skin-tolerant ester sunscreen ester, and at least one volatile liquid. The invention also outlines a method for administering systemic acting antiParkinson agents to animals through this drug delivery system.

Career Highlights

Timothy Morgon is associated with Acrux DDS Pty Ltd, a company that specializes in drug delivery technologies. His work at Acrux has allowed him to focus on developing advanced solutions for medication administration, enhancing patient outcomes in the treatment of Parkinson's disease.

Collaborations

Morgon has collaborated with several professionals in his field, including Kathryn Traci-Jane Klose and Barry Leonard Reed. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Timothy Matthias Morgon is a pioneering inventor whose work in transdermal drug delivery systems has the potential to significantly impact the treatment of Parkinson's disease. His innovative approach and dedication to improving medical technology are commendable.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…